FAM168A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.69680000003692E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.305840E-02 |
Normal-vs-Stage2 |
8.4742000000082E-05 |
Normal-vs-Stage3 |
6.80120004759033E-09 |
Normal-vs-Stage4 |
1.68239999709385E-09 |
Stage1-vs-Stage2 |
5.195700E-02 |
Stage1-vs-Stage3 |
7.70450000000533E-05 |
Stage1-vs-Stage4 |
2.9110999999471E-06 |
Stage2-vs-Stage3 |
2.933000E-01 |
Stage2-vs-Stage4 |
1.064230E-01 |
Stage3-vs-Stage4 |
5.360400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.65610000002481E-06 |
Normal-vs-AfricanAmerican |
1.81254999999103E-05 |
Normal-vs-Asian |
8.674800E-01 |
Caucasian-vs-AfricanAmerican |
8.708000E-02 |
Caucasian-vs-Asian |
2.833800E-01 |
AfricanAmerican-vs-Asian |
1.041170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.28280000000203E-06 |
Normal-vs-Female |
1.89146999999279E-05 |
Male-vs-Female |
9.078200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.459300E-03 |
Normal-vs-Age(41-60Yrs) |
5.155100E-04 |
Normal-vs-Age(61-80Yrs) |
1.4451999996723E-07 |
Normal-vs-Age(81-100Yrs) |
3.280700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.849000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.539000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.509000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.384500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.635980E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.726400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.462200E-01 |
Normal-vs-Grade 2 |
1.638310E-03 |
Normal-vs-Grade 3 |
6.88810000037954E-07 |
Normal-vs-Grade 4 |
2.38150055231756E-10 |
Grade 1-vs-Grade 2 |
8.786100E-02 |
Grade 1-vs-Grade 3 |
1.551620E-02 |
Grade 1-vs-Grade 4 |
2.184000E-04 |
Grade 2-vs-Grade 3 |
3.913900E-02 |
Grade 2-vs-Grade 4 |
6.35740000000107E-05 |
Grade 3-vs-Grade 4 |
1.369800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.356100E-02 |
Normal-vs-ccB subtype |
3.41520000002316E-06 |
ccA subtype-vs-ccB subtype |
5.641500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.5401000000036E-06 |
Normal-vs-N1 |
1.167610E-01 |
N0-vs-N1 |
8.036200E-01 |
|
|